Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway (URGENT): A Randomized Control Trial of Respiratory PCR Versus Standard Care

NCT05467007 is registered in ClinicalTrials.gov with Andrew Meltzer as lead sponsor.

NCT NCT05467007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05467007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway (URGENT): A Randomized Control Trial of Respiratory PCR Versus Standard Care
Lead sponsor
Andrew Meltzer
Phase
Not applicable
Overall status
Completed
Start date
April 4, 2022
Completion date
June 1, 2023
Enrollment
360 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, upper resp tract infection, viral infection